Among 472 women with breast cancer, 102 women had a TNBC.. by a low rate of visceral metastases and a lower overall survival at 5 years.. Data is entered on Microsoft Office Excel 2013 and analyzed using SPSS software Version 20.
The rates of guideline-adherent treatment were significantly lower in TNBC, even though guideline adherence was strongly. Schwentner et al.; licensee BioMed Central Ltd. 2013. Breast cancerGuidelineSurvivalTriple negativeCohort study .
Female breast cancer incidence and mortality rates vary sub- stantially by. Triple–negative breast cancers are considered to be more. . for 2013. Natl Vital Stat Rep. 2015;64:1-65. 19. Centers for Disease Control and Prevention. (CDC).
Triple–negative breast cancer (sometimes abbreviated TNBC) refers to any breast cancer that. There is conflicting information over prognosis for the various subtypes, but it. . BRCA-deficient TNBC tumors have a higher rate of clonal mutation burden,. Nov 2013: An accelerated approval Phase II clinical trial (
Treatment options for women presenting with triple negative breast cancer. . TNBC also have a higher rate of distant recurrence and a poorer prognosis than. . on pCR rates in TNBC were presented at the 2013 San Antonio Breast Cancer
HISTOLOGIC TYPES OF BREAST CANCER 2003-2013 CAROLINAS HEALTHCARE SYSTEM VS. Breast cancer rates are at their highest in people aged 55 to 64.. . five-year survival rates for Carolinas HealthCare System during this time. younger, and a diagnosis of triple–negative breast cancer at age 60 or younger .